Retrospective multicentre study on the effectiveness of first‐line direct‐acting antivirals against hepatitis C virus genotype‐1

WHAT IS KNOWN AND OBJECTIVE: In Japan, ledipasvir/sofosbuvir, elbasvir/grazoprevir and glecaprevir/pibrentasvir are recommended as first‐line treatments for patients with untreated hepatitis C virus genotype 1. Although they have demonstrated a high efficacy in clinical trials, there are no direct c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaya, Michihiro, Nakamura, Kazuyo, Sugiyama, Kyohei, Kinae, Ayumi, Yamaguchi, Hiromi, Ukita, Hirotoshi, Odagiri, Keiichi, Ujiie, Chika, Kato, Jun, Kageyama, Fujito, Nagura, Mariko, Matsushita, Kumi, Sugiue, Kaori, Ishida, Hiroki, Endo, Shinya, Suzuki, Takaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543670/
https://www.ncbi.nlm.nih.gov/pubmed/35229326
http://dx.doi.org/10.1111/jcpt.13624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543670/
https://www.ncbi.nlm.nih.gov/pubmed/35229326
http://dx.doi.org/10.1111/jcpt.13624

Ejemplares similares